Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages

References

• KapikianAZMitchellRHChanockRMShvedoffRAStewartCEAn epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccineAm J Epidemiol19698944054214305197
   PubMed Web of Science ®Google Scholar
• JohnsonTRParkerRAJohnsonJEGrahamBSIL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challengeJ Immunol200317042037204512574374
   PubMedGoogle Scholar
• CastilowEMOlsonMRVargaSMUnderstanding respiratory syncytial virus (RSV) vaccine-enhanced diseaseImmunol Res2007391–322523917917067
   PubMed Web of Science ®Google Scholar
• ZeltinsAConstruction and characterization of virus-like particles: a reviewMol Biotechnol20135319210723001867
   PubMed Web of Science ®Google Scholar
• QuanFSKimYLeeSViruslike particle vaccine induces protection against respiratory syncytial virus infection in miceJ Infect Dis2011204798799521881112
   PubMed Web of Science ®Google Scholar
• McGinnesLWGravelKAFinbergRWAssembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteinsJ Virol201185136637720980510
   PubMed Web of Science ®Google Scholar
• LeeSQuanFSKwonYAdditive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteinsAntiviral Res201411112913525239522
   PubMed Web of Science ®Google Scholar
• MurawskiMRMcGinnesLWFinbergRWNewcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathologyJ Virol20108421110112319889768
   PubMed Web of Science ®Google Scholar
• KoEJKwonYMLeeJSVirus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cellsNanomedicine20151119910825109662
   PubMed Web of Science ®Google Scholar
• BowdenDHThe alveolar macrophageEnviron Health Perspect1984553273416376105
   PubMed Web of Science ®Google Scholar
• SibilleYReynoldsHYMacrophages and polymorphonuclear neutrophils in lung defense and injuryAm Rev Respir Dis199014124715012405761
   PubMed Web of Science ®Google Scholar
• RubinsJBAlveolar macrophages: wielding the double-edged sword of inflammationAm J Respir Crit Care Med2003167210310412524246
   PubMed Web of Science ®Google Scholar
• SchneiderCNobsSPHeerAKAlveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infectionPLoS Pathog2014104e100405324699679
   PubMed Web of Science ®Google Scholar
• BracialeTJSunJKimTSRegulating the adaptive immune response to respiratory virus infectionNat Rev Immunol201212429530522402670
   PubMed Web of Science ®Google Scholar
• KimTSBracialeTJRespiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responsesPLoS One200941e420419145246
   PubMed Web of Science ®Google Scholar
• HoltPGOliverJBilykNDownregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophagesJ Exp Med199317723974078426110
   PubMed Web of Science ®Google Scholar
• van RooijenNSandersAvan den BergTKApoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidineJ Immunol Methods1996193193998690935
   PubMedGoogle Scholar
• Van RooijenNSandersALiposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applicationsJ Immunol Methods19941741–283938083541
   PubMed Web of Science ®Google Scholar
• LeeJSKwonYMHwangHSBaculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virusVaccine201432445866587425173478
   PubMedGoogle Scholar
• van RooijenNHendrikxELiposomes for specific depletion of macrophages from organs and tissuesMethods Mol Biol201060518920320072882
   PubMedGoogle Scholar
• ThepenTVan RooijenNKraalGAlveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in miceJ Exp Med198917024995092526847
   PubMedGoogle Scholar
• LeeYTSuarez-RamirezJEWuTEnvironmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytesJ Virol20118594085409421345961
   PubMed Web of Science ®Google Scholar
• HwangHSKwonYMLeeJSCo-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitisAntiviral Res201411011512325110201
   PubMed Web of Science ®Google Scholar
• MeyerholzDKGriffinMACastilowEMVargaSMComparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation modelToxicol Pathol200937224925519181630
   PubMed Web of Science ®Google Scholar
• MartinTRFrevertCWInnate immunity in the lungsProc Am Thorac Soc20052540341116322590
   PubMedGoogle Scholar
• HallJDWoolardMDGunnBMInfected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112Infect Immun200876125843585218852251
   PubMed Web of Science ®Google Scholar
• van RooijenNBakkerJSandersATransient suppression of macrophage functions by liposome-encapsulated drugsTrends Biotechnol19971551781859161052
   PubMedGoogle Scholar
• SungSSFuSMRoseCEJrGaskinFJuSTBeatySRA major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteinsJ Immunol200617642161217216455972
   PubMed Web of Science ®Google Scholar
• BeatySRRoseCEJrSungSSDiverse and potent chemokine production by lung CD11b high dendritic cells in homeostasis and in allergic lung inflammationJ Immunol200717831882189517237439
   PubMedGoogle Scholar
• BuenoSMGonzálezPARiedelCACarreñoLJVásquezAEKalergisAMLocal cytokine response upon respiratory syncytial virus infectionImmunol Lett2011136212212921195729
   PubMed Web of Science ®Google Scholar
• VargaSMWissingerELBracialeTJThe attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responsesJ Immunol2000165116487649511086089
   PubMed Web of Science ®Google Scholar
• JohnsonTRGrahamBSSecreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanismJ Virol199973108485849510482601
   PubMedGoogle Scholar
• BuenoSMGonzálezPAPachecoRHost immunity during RSV pathogenesisInt Immunopharmacol20088101320132918687294
   PubMed Web of Science ®Google Scholar
• BatakiELEvansGSEverardMLRespiratory syncytial virus and neutrophil activationClin Exp Immunol2005140347047715932508
   PubMed Web of Science ®Google Scholar
• BemRADomachowskeJBRosenbergHFAnimal models of human respiratory syncytial virus diseaseAm J Physiol Lung Cell Mol Physiol20113012L148L15621571908
   PubMed Web of Science ®Google Scholar
• CastilowEMMeyerholzDKVargaSMIL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced diseaseJ Immunol200818042376238418250447
   PubMed Web of Science ®Google Scholar
• CastilowEMLeggeKLVargaSMCutting edge: eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced diseaseJ Immunol2008181106692669618981084
   PubMedGoogle Scholar
• PrestwoodTRMorarMMZellwegerRMGamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient miceJ Virol20128623125611257022973027
   PubMed Web of Science ®Google Scholar